-
Adapting and exporting the Dutch Hogeweyk model to the U.S. is no easy feat. But one of the largest memory care operators in the U.S. is currently forging ahead with a new concept that emulates the famous community. The operator, Lutheran Senior Services (LSS), runs the Meramec Bluffs Senior Living community in St. Louis, Missouri. […]
-
Swiss-based biotech company Asceneuron has successfully raised an additional $100 million for the development of drug therapies that target proteins linked to Alzheimer’s disease and other cognitive brain conditions. The Series C financing will advance the clinical development of drug therapies known as OGA inhibitors for the treatment of neurodegenerative diseases, according to the company. […]
-
The Memory Care Innovation program is designed to recognize passionate and innovative industry members who are shaping the future of cognitive care across behavioral health, home health and home care, hospice and palliative care, senior housing, and skilled nursing. To see this year’s inaugural Memory Care Innovation Award winners, visit https://innovation.memorycarebusiness.com/. To become a Memory […]
-
The Memory Care Innovation program is designed to recognize passionate and innovative industry members who are shaping the future of cognitive care across behavioral health, home health and home care, hospice and palliative care, senior housing, and skilled nursing. To see this year’s inaugural Memory Care Innovation Award winners, visit https://innovation.memorycarebusiness.com/. To become a Memory […]
-
Memory care operators and health systems can better collaborate to improve dementia care while demonstrating value through cost savings and improved outcomes. That’s according to Dr. John Sawyer, who is the co-director at the Center for Brain Health of Ochsner Health. Sawyer envisions a future where memory care operators and health systems can mutually benefit […]
-
Mississippi, Alabama and Washington are the top three states with the highest death rates for people living with Alzheimer’s disease. That’s according to U.S. News & World Report, which combed through publicly available data from the U.S. Centers for Disease Control and Prevention (CDC) that tracked the causes of death among people in 2022. Alzheimer’s, […]
-
Doctors have a new drug to prescribe to treat Alzheimer’s disease. Earlier this month, the U.S. Food and Drug Administration (FDA) approved the use of the drug, donanemab, which maker Eli Lilly plans to sell under the brand name Kisunla. The drug is administered through a monoclonal antibody infusion every four weeks, and is used […]
-
Memory care operators are gearing up for deeper participation in the new Guiding an Improved Dementia Experience (GUIDE) program from the Centers for Medicare and Medicaid Services (CMS), which officially launched this week. More than 400 healthcare organizations are participating in dementia care programs, from senior living operators to health systems and beyond. Organizations including […]
-
Vi is rolling out a new “brain gym” pilot program aimed at improving brain health and cognitive function at its life plan community in La Jolla, California. The Chicago-based operator at Vi at La Jolla Village conducted a case study with 37 residents to improve cognitive function. The operator worked with Dividat, a cognitive motor […]
-
Faced with challenges on many sides, memory care operators are integrating technology into their operations, from artificial intelligence to virtual reality and other tools. “It really streamlines the process and gives you immediate, actionable information to engage with the resident, making it a more personal experience, while also allowing the staff to engage without having […]